Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakner

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Orvosi Hetilap|April 24, 2016
[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study]Mariann Rutka, Anita Bálint, Klaudia Farkas, et al.
Journal of Crohn'S & Colitis|September 23, 2015
Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical PracticeAnita Bálint, Klaudia Farkas, Károly Palatka, et al.
Expert Opinion on Biological Therapy|November 30, 2019
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort studyRenáta Bor, Anna Fábián, Mária Matuz, et al.
Journal of Crohn'S & Colitis|December 15, 2015
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide CohortKrisztina B Gecse, Barbara D Lovász, Klaudia Farkas, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Protein Science : a Publication of the Protein Society|April 25, 2012
The interface of protein structure, protein biophysics, and molecular evolutionDavid A Liberles, Sarah A Teichmann, Ivet Bahar, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
The Journal of Infection|April 25, 2024
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationJulien De Greef, Dina Averbuch, Laura Tondeur, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Orvosi Hetilap|April 24, 2016
[Long-term adalimumab therapy in ulcerative colitis in clinical practice: result of the Hungarian multicenter prospective study]Mariann Rutka, Anita Bálint, Klaudia Farkas, et al.
Journal of Crohn'S & Colitis|September 23, 2015
Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical PracticeAnita Bálint, Klaudia Farkas, Károly Palatka, et al.
Expert Opinion on Biological Therapy|November 30, 2019
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort studyRenáta Bor, Anna Fábián, Mária Matuz, et al.
Journal of Crohn'S & Colitis|December 15, 2015
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide CohortKrisztina B Gecse, Barbara D Lovász, Klaudia Farkas, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Protein Science : a Publication of the Protein Society|April 25, 2012
The interface of protein structure, protein biophysics, and molecular evolutionDavid A Liberles, Sarah A Teichmann, Ivet Bahar, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
The Journal of Infection|April 25, 2024
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow TransplantationJulien De Greef, Dina Averbuch, Laura Tondeur, et al.
Pageof 16